Pure White Cell Aplasia Complicated by Systemic Sclerosis with Accompanying Scleroderma Renal Crisis

Intern Med. 2022 Jun 15;61(12):1907-1912. doi: 10.2169/internalmedicine.8436-21. Epub 2021 Nov 20.

Abstract

Pure white cell aplasia (PWCA) is a rare neutropenic disorder caused by absence of neutrophil-lineage cells. A 49-year-old man was diagnosed with scleroderma renal crisis 2 months prior to admission to Ohta-Nishinouchi Hospital after experiencing a fever and abdominal pain. Blood tests revealed severe neutropenia, and bone marrow aspirate showed the absence of neutrophil-lineage cells. He was diagnosed with PWCA. Steroids alone were not effective, but adding cyclosporine A and high-dose immunoglobulin recovered his neutropenia and improved his condition. Cyclosporine A and high-dose immunoglobulin are thus considered effective for treating PWCA in autoimmune diseases.

Keywords: cyclosporine A; high dose intravenous immunoglobulin; pure white cell aplasia; scleroderma renal crisis; systemic sclerosis.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury* / drug therapy
  • Cyclosporine / therapeutic use
  • Humans
  • Hypertension, Renal*
  • Male
  • Middle Aged
  • Neutropenia* / drug therapy
  • Scleroderma, Localized* / complications
  • Scleroderma, Systemic* / complications
  • Scleroderma, Systemic* / drug therapy

Substances

  • Cyclosporine